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Mass spectrometry-based methods have allowed elucidation of alterations in complex
proteomes, such as eukaryotic cells. Such studies have identified and measured relative
abundances of thousands of host proteins after cells are infected with a virus. One of
the potential limitations in such studies is that generally only the most abundant proteins
are identified, leaving the deep richness of the cellular proteome largely unexplored. We
differentially labeled HeLa cells with light and heavy stable isotopic forms of lysine and
arginine and infected cells with reovirus strain T3D. Cells were harvested at 24 h post-
infection. Heavy-labeled infected and light-labeled mock-infected cells were mixed together
1:1. Cells were then divided into cytosol and nuclear fractions and each fraction analyzed,
both by standard 2D-HPLC/MS, and also after each fraction had been reacted with a ran-
dom hexapeptide library (Proteominer® beads) to attempt to enrich for low-abundance
cellular proteins. A total of 2,736 proteins were identified by two or more peptides at
>99% confidence, of which 66 were significantly up-regulated and 67 were significantly
down-regulated. Up-regulated proteins included those involved in antimicrobial and antiviral
responses, GTPase activity, nucleotide binding, interferon signaling, and enzymes asso-
ciated with energy generation. Down-regulated proteins included those involved in cell
and biological adhesion, regulation of cell proliferation, structural molecule activity, and
numerous molecular binding activities. Comparisons of the r2 correlations, degree of
dataset overlap, and numbers of peptides detected suggest that non-biased enrichment
approaches may not provide additional data to allow deeper quantitative and comparative
mining of complex proteomes.
Keywords: RNA virus, virus infection, host cell alterations, mass spectrometry, liquid chromatography,
bioinformatics
INTRODUCTION
The mammalian reoviruses (MRV) are non-enveloped viruses
with genomes consisting of 10 segments of double-stranded RNA.
MRV is the prototype member of the Orthoreovirus genus in the
Reoviridae family and was first isolated in the respiratory and
enteric tracts of healthy humans in the early 1950s. MRV infec-
tions are generally mild in humans. The Orthoreoviruses include
non-fusogenic MRV and fusogenic avian reovirus. MRV consist of
three serotypes. Each serotype has prototype strains: strain Lang
(T1L) for serotype 1, strain Jones (T2J) for serotype 2, and strain
Dearing (T3D) for serotype 3 (Tran and Coombs, 2006; Schiff
et al., 2007). One of the most potentially useful characteristics of
MRV is its ability to selectively kill certain cancer cells (Coffey
et al., 1998; Forsyth et al., 2008; Thirukkumaran et al., 2010). An
activated Ras pathway and functional p53 appear to be require-
ments for this selective oncolytic property (Coffey et al., 1998; Pan
et al., 2011). Global analyses of oligonucleotide microarrays have
detected activation of numerous cellular genes, including many
related to apoptosis (Poggioli et al., 2002; DeBiasi et al., 2003).
However, global alterations in proteins (the effector molecules)
after MRV infection have not yet been reported.
Except for certain epigenetic events (reviewed in Goldberg et al.,
2007), a cell’s genome generally remains relatively constant. How-
ever, the cell’s proteome (the total protein repertoire, including
all co-translational and post-translational modifications) varies
greatly due to its biochemical interactions with the genome, as
well as the cell’s interactions with the environment. In the case of
viruses, which require the host cell’s machinery and metabolism
to replicate, the cell’s proteome also reflects the specific alterations
of the pathways induced by virus infection.
Previous analyses of how cells respond to virus infection have
used microarray technologies which measure the cellular “tran-
scriptome” (see for example; Geiss et al., 2002; Kobasa et al.,
2007). However, there frequently is little concordance between
microarray and protein data (Tian et al., 2004; Baas et al., 2006),
partly because mRNA levels cannot provide complete information
about levels of protein synthesis or extents of post-translational
modifications. Thus, proteomic analyses have also been employed
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to better understand host alterations induced by virus infec-
tion. These have included two-dimensional difference in gel elec-
trophoresis (2D-DIGE; see for examples; Burgener et al., 2008;
Lucitt et al., 2008), isotope coded affinity tags (ICAT; Booy et al.,
2005; Stewart et al., 2006), isobaric tags for relative and absolute
quantitation (iTRAQ; Dwivedi et al., 2009; Zhang et al., 2009), and
stable isotope labeling by amino acids in cell culture (SILAC; Skiba
et al., 2008). We have previously used SILAC to measure proteomic
alterations in influenza virus-infected A549 cells (Coombs et al.,
2010). Cells were labeled with either 12C6-Lys and12C614N4-Arg
(“light”; L), or13C6-Lys and 13C615N4-Arg (“heavy”; H), because
virtually every tryptic peptide is expected to contain an L or H
label, thereby providing increased protein coverage. In addition,
L and H samples are mixed together early in this process, thereby
reducing sample-to-sample variability.
Most quantitative proteomic analyses succeed in identifying
and measuring several 1,000 proteins. Head-to-head compar-
isons suggest SILAC identifies more proteins than other methods
(reviewed in Coombs, 2011); however, the 3,000–5,000 identi-
fied in many such studies still represents a small fraction of the
estimated entire eukaryotic proteome. It is generally assumed
that high-abundance proteins are most easily detected and low-
abundance proteins masked by other components (Zolotarjova
et al., 2008). Some studies have attempted to deplete high-
abundance proteins (for example Dwivedi et al., 2009) or to use
methods to enrich for selected proteins (Jiang et al., 2007). Both
of these methods potentially suffer from selective bias for specific
proteins. We decided to attempt to enrich for low-abundance pro-
teins by using Proteominer™ (PM) beads (Bio-rad), which consist
of a“library”of 64 million random hexapeptides to non-selectively
bind interacting partners. We succeeded in the current study
in identifying and measuring 2,736 host proteins. Sixty six pro-
teins were significantly up-regulated, including those involved in
antimicrobial and antiviral responses, GTPase activity, nucleotide
binding, interferon signaling, and enzymes associated with energy
generation. Sixty seven proteins, including those involved in cell
and biological adhesion, regulation of cell proliferation, struc-
tural molecule activity, and numerous molecular binding activities
were significantly down-regulated. However, comparison of the
numbers of proteins identified with or without PM enrichment
suggests this type of non-biased enrichment may not contribute
substantially to deeper proteomic elucidation.
MATERIALS AND METHODS
CELLS AND VIRUSES
Cell lines
Spinner-adapted mouse fibroblast L929 cells (L929) were grown
in Joklik’s modified minimal essential medium (J-MEM; Gibco,
Grand Island, NY, USA) supplemented with 6% fetal bovine
serum (FBS; Hyclone, Rockford, IL, USA), and 2 mM l-glutamine
as described (Berard and Coombs, 2009). Reovirus was grown
according to standard lab practice (Berard and Coombs, 2009).
Human HeLa cells were routinely cultured in Dulbecco’s mod-
ified MEM (DMEM) supplemented with non-essential amino
acids, sodium pyruvate, 0.2% (w/v) glucose, 10% FBS (Hyclone),
and 2 mM l-glutamine. Cells were maintained as monolayers in
5% CO2 and were passaged by trypsinization 2–3 times each week.
For SILAC labeling, cells were grown in DMEM media provided
with a SILAC™ Phosphoprotein Identification and Quantification
Kit (Invitrogen Canada Inc., Burlington, ON, Canada), supple-
mented as above (except without non-essential amino acids), and
with 10% dialyzed FBS (Invitrogen Canada Inc.), plus 100 mg each
of “light” (L) or “heavy” (H) l-lysine and l-arginine per liter of
DMEM.
Viruses
Reovirus strain Type 3 Dearing (T3D) is a laboratory stock. Virus
amplifications were routinely performed in L929 cell monolayers
grown in the presence of 5% CO2 at 37˚C, supplemented with
J-MEM as described above, except with 3% FBS instead of 6%
FBS in the cell culture media, 100 U/ml of penicillin, 100µg/ml
streptomycin sulfate, and 100µg/ml amphotericin-B as previously
described (Berard and Coombs, 2009).
Virus purification
Large amounts of reovirus T3D were grown in 1 l suspension L929
cell cultures and purified by routine procedures involving Vertrel-
XF™ extraction and cesium chloride (CsCl) ultracentrifugation
(Mendez et al., 2000). Purified virions were then dialyzed against
D-Buffer (150 mM NaCl, 15 mM MgCl2, 10 mM Tris, pH 7.4).
Virus concentration was measured by optical density at 260 nm,
using the relationship 1 ODU= 2.1× 1012 particles per milliliter
(Smith et al., 1969) and infectivity was titrated.
Virus titrations
Serial 1:10 dilutions of virus samples were made in gel saline
(137 mM NaCl, 0.2 mM CaCl2, 0.8 mM MgCl2, 19 mM HBO3,
0.1 mM Na2B4O7, and 0.3% w/v gelatin). HeLa cell and L929 cell
monolayers in six-well plates were infected in duplicate, viruses
allowed to attach to cells for 1 h with periodic rocking, and each
well overlaid with a 50:50 ratio of 2% agar and 2× Medium 199
(M199) supplemented with a final concentration of 3% FBS, 2 mM
l-glutamine, 100 U/ml of penicillin, 100µg/ml streptomycin sul-
fate, and 100µg/ml amphotericin-B. Plates were fed 3 days later
with fresh agar/M199 and were stained with a 0.04% neutral red
solution on day 6. Viral plaques were counted 15–18 h later and
titers calculated (Berard and Coombs, 2009).
SILAC infection
Once HeLa cells had grown through six doublings in appropri-
ate SILAC media, H cells were infected with gradient-purified
T3D at a multiplicity of infection (MOI) of seven plaque form-
ing units (PFU) per cell. An equivalent number of L cells were
mock-infected with diluent as control. Cells were overlaid with
appropriate media and cultured for 24 h.
CELL FRACTIONATION
At 24hpi, L and H cells in the T75 flasks were collected and
counted. To verify infection status of each culture, aliquots of all
cultures were saved for virus titration. For comparative SILAC
assays, equivalent numbers of L and H cells were mixed together,
and the mixed cells were washed 3× in >50 volumes of ice-cold
Phosphate Buffered Saline (PBS). Washed cells were lysed with
0.5% NP-40, supplemented with 1.1µM pepstatin A, incubated
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on ice for 30 min, and nuclei removed by pelleting at 5,000× g
for 10 min. The cytosol and soluble membranes (supernatant)
were transferred to a fresh microfuge tube; and the two frac-
tions (nuclear pellet and supernatant) were frozen at−80˚C until
further processing took place.
Thawed nuclei were extracted with one volume of High Salt
Buffer (620 mM NaCl, 1 mM DTT, 10 mM Tris, pH 8.0), insoluble
material pelleted at 15,000× g for 10 min, and the supernatant
removed and saved. Insoluble pellets were then extracted with
1/3rd volume of 8 M urea, insoluble material pelleted as above,
the two extractions combined, and samples stored at −80˚C until
further processing took place.
PROTEOMINER™ PURIFICATION
Approximately 90% of each fraction (cytosol and nucleus) was
passed through separate PM Mini columns. The columns were
processed according to manufacturer’s protocol (Bio-Rad Corp).
Briefly, the cytosolic and nuclear protein fractions were measured
and each fraction concentrated to≈20 mg/ml (∼1 ml). PM beads
were washed twice with Wash Buffer then incubated with each
concentrated protein sample for 2 h with end-to-end shaking.
Columns were spun at 1,000× g for 2 min to remove excess fluid,
washed 3×with Wash Buffer, and then bound proteins eluted with
two sequential applications of 200µl One-step Elution Buffer.
WESTERN BLOTTING
Western blot analyses of HeLa cells were performed essentially
as described previously (Coombs et al., 2010). Briefly, unlabelled
cells were harvested essentially as described above and cytoso-
lic proteins were resolved on a 10% SDS-PAGE gel at 120 V
for 70 min. Proteins were transferred to polyvinylidenedifluoride
(PVDF) membranes at 20 V for 30 min in a semi-dry appa-
ratus, and the transfer confirmed by Ponceau staining. Mem-
branes were blocked with 5% skim milk in TBST and probed
with various antibodies in 1% BSA in TBST. Primary antibod-
ies were: in-house rabbit anti-reovirus,α-GAPDH (Cell Signaling,
cat#2118), α-IFIT2 (Abcam, cat#ab55837), and α-SAMD9 (Sigma
cat#HPA021318), goat α-Mx1 (Santa Cruz cat#sc-34128), and
mouse anti-STAT1 (Cell Signaling, cat#9176), α-Actin (Sigma,
cat#A5441). The secondary antibodies were the appropriate horse-
radish peroxidase (HRP)-conjugated rabbit anti-mouse or goat
anti-rabbit (Cell Signaling, cat#7076 and cat#7074, respectively).
Bands were detected by enhanced chemiluminescence using an
Alpha Innotech FluorChem Q Multi Image III instrument.
IMMUNOFLUORESCENT MICROSCOPY
HeLa cells were grown overnight in a 37˚C, 5% CO2 incubator
to 80% confluency on autoclaved 12-spot slides and then infected
with MRV T3D at a MOI of seven or mock-infected. Mock, 0, 6,
12, and 24 h infected cells were washed 5× with PBS and fixed
with 4% paraformaldehyde for 15 min at 4˚C. Cells were then
washed 4× with 1× PBS and kept in 1× PBS at 4˚C until the
24 h time point was collected. Cells from all time points were then
permeabilized with 0.1% TritonX-100 in 1× PBS for 5 min at 4˚C
followed by five washes with 1× PBS. Cells were blocked with 1%
BSA in 1× PBS and then treated with primary antibody (in-house
rabbit anti-reovirus). Cells were then washed 5× with 1× PBS
and treated with Alexa Fluor® 488 Goat anti-Rabbit (Invitrogen,
cat#A11008) secondary antibody (all antibodies were diluted in
1% BSA in 1× PBS). Cells were then washed 5× with 1× PBS
and Anti-fade prolong gold reagent with DAPI (Invitrogen, Cat#
P36935) was added to each spot before slides were covered with
coverslips, dried, and sealed. Slides were examined on a Zeiss Axio
Observer Z1 inverted microscope using 10 and 20× objectives and
fluorescence illumination using ExfoXcite. Images were acquired
using AxioVision 4.8.2 software.
PROTEIN DIGESTION
Protein content in the non-purified (“standard”) and PM-purified
cytosolic and nuclear fractions collected as described above were
determined using a BCA™ Protein Assay Kit (Pierce; Rockford, IL,
USA) and BSA standards. After protein concentration determina-
tions, samples were diluted with freshly made 100 mM ammonium
bicarbonate to provide concentrations of ∼1 mg/ml and pH∼ 8.
Three hundred microliters of each sample (∼300µg of pro-
tein) were reduced, alkylated, and trypsin digested as previously
described (Coombs et al., 2010). Briefly, 30µl of freshly prepared
100 mM dithiothreitol (DTT) in 100 mM ammonium bicarbonate
was added, incubated for 45 min at 60˚C, 30µl of freshly prepared
iodoacetic acid (500 mM solution in 100 mM ammonium bicar-
bonate) was added,and the tubes were then incubated for 30 min at
room temperature, in the dark. Finally, 50µl of 100 mM DTT solu-
tion was added to quench the excess iodoacetic acid. Samples were
digested overnight at 37˚C with 6µg of sequencing grade trypsin
(Promega, Madison, WI, USA). The samples were lyophilized and
stored at−80˚C.
PEPTIDE FRACTIONATION USING 2D RP HPLC
A newly developed orthogonal procedure (Gilar et al., 2005; Spicer
et al., 2007) was employed for 2D RP (reversed-phase) high pH –
RP low pH peptide fractionation. Lyophilized tryptic digests were
dissolved in 200µl of 20 mM ammonium formate pH 10 (buffer
A for first dimension separation), injected onto a 1 mm× 100 mm
XTerra (Waters, Milford, MA, USA) column and fractionated
using a 0.67% acetonitrile per minute linear gradient (Agilent
1100 Series HPLC system, Agilent Technologies, Wilmington, DE,
USA) at a 150µl/min flow rate. Sixty one-minute fractions were
collected (covering ∼40% acetonitrile concentration range) and
concatenated using procedures described elsewhere (Spicer et al.,
2007; Dwivedi et al., 2008); the last 30 fractions were combined
with the first 30 fractions in sequential order (i.e., #1 with #31;
#2 with #32, etc.). Combined fractions were vacuum-dried and
re-dissolved in buffer A for the second dimension RP separation
(0.1% formic acid in water).
A split less nano-flow Tempo LC system (Eksigent, Dublin,
CA, USA) with 20µl sample injection via a 300µm× 5 mm
PepMap 100 pre-column (Dionex, Sunnyvale, CA, USA) and a
100µm× 200 mm analytical column packed with 5µm Luna
C18(2; Phenomenex, Torrance, CA, USA) were used in the sec-
ond dimension separation prior to MS analysis. Both eluents A
(water) and B (acetonitrile) contained 0.1% formic acid as an ion-
pairing modifier. A 0.33% acetonitrile per minute linear gradient
(0–30% B) was used for peptide elution, providing a total 2 h run
time per fraction in the second dimension.
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FIGURE 1 | Outline of experimental set-up. Cells were passaged through
six doublings in either Light or Heavy SILAC medium and the H cells infected
with reovirus T3D. Infected (H) and mock-infected (L) cells were mixed
together 1:1. After the cells were washed and lysed to separate cytosol from
nucleus, 95–95% of each fraction was non-specifically enriched for
low-abundance proteins by reaction with Proteominer™(PM) beads. Each of
the four fractions (two PM-enriched as well as two residual 3–5% “standard”
fractions) were then processed by 2D-HPLC/MS.
MASS SPECTROMETRY, BIOINFORMATICS, AND DATA MINING
A QStar Elite mass spectrometer (Applied Biosystems, Foster City,
CA, USA) was used in a data-dependent MS/MS acquisition mode.
One-second survey MS spectra were collected (m/z 400–1,500)
followed by MS/MS measurements on the three most intense par-
ent ions (80 counts/s threshold,+2±4 charge state, m/z 100–1,500
mass range for MS/MS), using the manufacturer’s “smart exit”
(spectral quality five) settings. Previously targeted parent ions were
excluded from repetitive MS/MS acquisition for 60 s (50 mDa mass
tolerance). Raw data files (30 in total for each run) were submitted
for simultaneous search using standard SILAC settings for QStar
instruments and were analyzed by Protein Pilot®, version 4.0, using
the non-redundant human gene database. A decoy database search
strategy (NCBInr Homo sapiens in which all protein sequences
were reversed) was used to estimate the false discovery rate, which
for this dataset was <0.8%. Proteins, and their confidences and
H:L ratios, were returned with GeneInfo Identifier gi accession
numbers. Proteins for which at least two fully trypsin digested L
and H peptides were detected at >99% confidence were used for
subsequent comparative quantitative analysis.
Differential regulation within each experimental dataset was
determined by normalization of each dataset, essentially as
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described (Keshamouni et al., 2009). Briefly, every H:L ratio was
converted into log2 space to determine geometric means and facil-
itate normalization. The average log2 H:L ratios and SDs of the
log2 H:L ratios were determined for each dataset. Every proteins’
log2 H:L ratio was then converted into a z-score, using the formula:
Z - score (σ) of [b] =
Log2H:L [b]− average of(
log2 of each member, a . . . n
)
standard deviation of(
log2 of each member, a . . . n
)
where “b” represents an individual protein in a dataset popula-
tion a. . .n, and z-score is the measure of how many SD units
(expressed as “σ”) that protein’s log2 H:L ratio is away from its
population mean. Thus, a protein with a z-score>1.645σ indicates
that protein’s differential expression lies outside the 90% confi-
dence level, >1.960σ indicates outside the 95% confidence level,
2.576σ indicates 99% confidence, and 3.291σ indicates 99.9% con-
fidence. z-Scores >1.960 were considered significant. gi numbers
of all significantly regulated proteins were converted into HGNC
identifiers by Uniprot1 and HGNC terms were submitted to and
analyzed by the DAVID bioinformatic suite at the NIAID, version
6.7 (Dennis et al., 2003; Huang et al., 2009a) and gene ontolo-
gies examined with the “FAT” datasets. The gi numbers were also
submitted to, and pathways constructed with, Ingenuity Pathway
Analysis software (IPA®).
RESULTS AND DISCUSSION
IDENTIFICATION OF ALTERED HOST PROTEINS
We combined∼108 H-labeled reovirus-infected HeLa cells with an
equivalent amount of L-labeled non-infected cells, lysed the cells
to generate cytosolic and nuclear fractions, and reacted ∼95% of
each fraction with a commercially available random hexapeptide
library (PM™) to enrich for low-abundance proteins. This strat-
egy was chosen to attempt to complement the proteomic coverage
of high-abundance and medium-abundance proteins expected
from standard 2D-HPLC/MS processing (outlined in Figure 1).
We also confirmed that the majority of HeLa cells demonstrated
virus replication under our experimental conditions by 12–24hpi,
as measured by immunofluorescent microscopy (Figure 2). Our
standard 2D-HPLC/MS process identified 2,472 proteins from
21,989 non-redundant H:L peptide pairs in the cytosolic fraction.
However, exclusion of those proteins whose identification confi-
dence was <99% reduced the number of identified proteins to
1,903 (Table 1; Figure 3A). Using similar criteria, we found 1,657
proteins at≥99% confidence in the cytosolic fraction reacted with
the PM library and about 1,100 proteins in each of the nuclear frac-
tions. Since crude nuclear fractions were frozen and no attempts
were made to remove traces of cytosolic proteins from this fraction,
these assays were meant to provide additional cell fractions rather
than to allow meaningful distributional characterization and the
“nuclear” fractions were expected to be contaminated with some
cytosolic proteins.
1http://www.uniprot.org/
Mock 
0 
6 
12 
24 
Infected 
FIGURE 2 | Confirmation of HeLa cell infectivity. HeLa cells were
mock-infected (left), or infected with MRV strain T3D at an MOI of 7 (right).
Cells were harvested at indicated times post-infection (left) and processed
for immunofluorescence microscopy, using in-house rabbit anti-reovirus and
Alexa-488-conjugated secondary anti-rabbit antibody (green) and DAPI
(blue). Scale bar is 50µm.
Combination of all fractions, and removal of all proteins iden-
tified by only a single peptide, resulted in identification and mea-
surement of 2,759 total unique protein pairs. Each protein’s H:L
ratio was converted to log space and inspection of each dataset
indicated variability in each dataset’s mean log2 value and in
each dataset’s log2 SD (Figure 3B; Table 1). Thus, every proteins’
H:L ratio was converted into a z-score as described in Section
“Materials and Methods” (and in Coombs et al., 2010) to facil-
itate comparisons of each dataset. A number of proteins with
significantly high or low log2 values and corresponding z-scores
represented keratins and other proteins identified in other studies
as probable contaminants (i.e., S200 binding proteins); thus, these
proteins were removed from further calculations.
Stratification of each protein’s H:L ratio and its corresponding
z-score indicated that numerous proteins in each sample could
be considered significantly regulated. For example, of the 1,838
proteins identified in the standard cytosolic preparation, 40 were
up-regulated at 95% confidence and 14 were also up-regulated
www.frontiersin.org September 2012 | Volume 3 | Article 310 | 5
Jiang et al. Quantitative proteominer analysis of reovirus T3D
Table 1 | Number of peptides, proteins, log2 H:L ratio means and SD, and z-scores of SILAC-measured HeLa cell proteins.
Cytosol Nuclei
Standard1 Proteominer2 Standard Proteominer
Total number of peptide pairs3 24,927 17,484 14,594 13,108
Total number of proteins4 1,903 1,657 1,104 1,135
Number of proteins analyzed5 1,838 1,570 1,047 1,064
Mean log2 H:L ratios 0.0124 0.0009 0.0055 0.0156
SD of log2 H:L ratios 0.2759 0.3526 0.3035 0.3314
Number of proteins at z -score cutoff of: ±1.960σ (95%) 40, 336 34, 27 32, 29 18, 20
±2.576σ (99%) 21, 17 19, 20 14, 15 14, 15
±3.291σ (99.9%) 14, 5 8, 17 11, 7 8, 11
1Indicated cellular fraction was trypsinized and directly processed by two-dimensional HPLC/MS.
2Indicated cellular fraction was incubated with Proteominer™ beads, eluted, trypsinized, and processed by 2-D HPLC/MS.
3Total number of H:L peptide pairs for all proteins identified at confidence level ≥99%.
4Total number of proteins identified at confidence level ≥99%.
5Number of proteins analyzed after those identified by only a single peptide, as well as possible contaminants, removed.
6First value is number of up-regulated proteins outside the indicated confidence level; second number is number of down-regulated proteins outside the indicated
confidence level.
at 99.9% confidence (Table 1). Thirty three proteins in the same
dataset were down-regulated at 95% confidence, and five of these
proteins were also down-regulated at 99.9% confidence. Inspec-
tion of protein H:L ratios and z-scores indicated that most proteins
differentially regulated at>95% confidence had H:L ratios altered
by >1.5-fold. Thus, proteins observed more than a single time
were considered significantly regulated if at least one of their
observations had a z-score ≥1.960σ, if another observation in
the same type of fraction (i.e., standard cytosolic and PM cytoso-
lic) was no more than 0.75σ in the opposite direction, and if the
average H:L ratio was >1.5-fold. Using the above criteria, we
identified and measured 66 proteins that were significantly up-
regulated and 67 proteins that were significantly down-regulated
(Table 2).
Several of the up-regulated and non-regulated proteins that
were identified and measured in the SILAC analysis were con-
firmed by Western blotting (Figure 4). Most Western blot results
confirmed the SILAC-determined results although some dif-
ferences in measured ratios probably reflect different levels of
sensitivity of the two assays.
PROTEINS UP-REGULATED BY REOVIRUS INFECTION ARE ASSOCIATED
WITH ANTIMICROBIAL AND ANTIVIRAL RESPONSES, GTPASE
ACTIVITY, NUCLEOTIDE BINDING, INTERFERON SIGNALING, AND
ENZYMES ASSOCIATED WITH ENERGY GENERATION
Proteins, and their levels of regulation, were analyzed by a vari-
ety of means. Protein gi numbers were imported into Uniprot
(see text foot note 1) and converted into HUGO nomenclature
committee (HGNC) identifiers. The HGNC IDs that represented
significantly up-regulated and down-regulated proteins at the 95%
confidence interval were then imported into DAVID (Dennis et al.,
2003; Huang et al., 2009b), gene identifications converted to Entrez
gene IDs by that suite of programs, and gene ontological biologi-
cal processes and molecular functions identified at 95% confidence
(Figure 5).
Up-regulated proteins were assigned to 18 GOTERM biologi-
cal processes at 95% confidence (Figure 5, upper), that included
cellular respiration, energy metabolism, and responses to viruses.
Up-regulated proteins were also assigned to 11 functional groups
(Figure 5) including primarily nucleotide binding. Protein gi
numbers and levels of regulation were also imported into the
Ingenuity Pathways Analysis (IPA®) tool which identified 13
GO categories (Figure 6A). Up-regulated proteins were enriched
in growth factor, ion channel, kinase, phosphatase, and trans-
membrane receptor categories, whereas there were proportionally
fewer up-regulated peptidase, translation regulators, and “other”
(unknown) categories. Interacting pathways were also constructed
by IPA. A total of 22 pathways were identified at a confidence level
of 95% or greater. Five of these pathways, each with 11 or more
“focus” members (significantly up- or down-regulated proteins),
shared common members, and it was possible to build a single,
merged pathway (Figure 6B). One other pathway (RNA post-
transcriptional modification) contained only five focus molecules.
The other 16 pathways consisted of several proteins, but contained
only a single focus protein (data not shown). The five networks
that contained 11 or more focus members corresponded to antimi-
crobial and inflammatory response; gastrointestinal disease; cell
cycle, death, growth, proliferation, and movement; and DNA repli-
cation pathways (Figure 6C). Proteins present in the pathways
and identified in our analyses as up-regulated are depicted in
shades of red and include FADS3, IFIT1, and SAP130. Proteins
present in the pathways and identified as down-regulated are
shown in green and include AZGP1, LTF, and WDR5. Proteins
present in the pathways and identified in our analyses, but nei-
ther up- nor down-regulated, are depicted in gray and include
NF-KB complex, MAPK1, and TUBB, and proteins known to
participate in the pathways but not identified in our analyses
are shown in white and include AGER, IL28A, and MARK1–3.
IPA analyses identify interaction nodes. For example, several of
the highly up-regulated proteins interact with few other proteins,
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FIGURE 3 | Distributions of proteins identified in various experiments.
(A) Venn diagram of numbers of identified proteins from various analyses.
(B) Frequency distributions of identified proteins in two virus-infected sample
sets, with H:L ratios expressed as log2 values. Positive values represent
up-regulated host proteins in virus-infected cells; negative values represent
down-regulated host proteins. Characteristics of all peptide and protein
distributions, mean log2 H:L ratios, and SDs of log2 H:L ratios are shown in
Table 1.
but some, such as STAT, ISG15, and Mx1 interact with four or
more. Many of these molecules are involved in innate immunity.
In addition, the interferon-induced, large GTPase dynamin-like
Mx proteins are important anti viral proteins, particularly against
RNA viruses (Haller and Kochs, 2002; Haller et al., 2009) and
have been identified in several proteomic studies as up-regulated
by influenza virus infection (Baas et al., 2006; Vester et al., 2009;
Coombs, 2011). In addition, modulation of interferon response by
reoviruses, including through STAT activation, has been demon-
strated (Goody et al., 2007; Sherry, 2009; Zurney et al., 2009).
Thus, our SILAC observations are validated by, and support, pre-
vious findings. Similarly, a few of the down-regulated proteins
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Table 2 | Significantly affected HeLa cell proteins after reovirus infection.
Accession HGNC ID Name Cytoplasm Nucleus
Standard Proteominer Standard Proteominer
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
UP-REGULATED PROTEINS
Proteins detected in multiple similar fractions
gi|8923450 SDHAF2 Succinate dehydrogenase assembly
factor 2, mitochondrial precursor
50.6 4 24.0362 4 0.526
gi|222136619 MX1 Myxovirus resistance protein 1 6.12 6 6.583 6 8.839 42.0 2 21.873 3 5.234
gi|116534937 IFIT1 Interferon-induced protein with
tetratricopeptide repeats 1 isoform 2
6.45 6 9.877 4 7.414 2.67 2 4.227
gi|55741675 K0907 Hypothetical protein LOC22889 4.59 3 −0.368 3 9.139
gi|4826649 RM49 Mitochondrial ribosomal protein L49 4.58 2 10.901 2 0.178 0.95 8 −0.266
gi|4826774 ISG15 ISG15 ubiquitin-like modifier 3.80 10 7.170 5 5.083 3.29 4 5.131
gi|27881482 DDX58 DEAD/H (Asp-Glu-Ala-Asp/His) box
polypeptide RIG-I
3.77 2 6.322 2 5.832
gi|6274552 STAT1 Signal transducer and activator of
transcription 1 isoform alpha
2.76 19 5.372 8 3.952 1.81 3 −1.456 6 3.663
gi|72534658 IFIT3 Interferon-induced protein with
tetratricopeptide repeats 3
2.57 2 0.803 5 4.660 1.02 1
gi|19743875 FUMH Fumaratehydratase precursor 1.02 25 0.240 16 −0.136 2.24 4 5.851 4 0.098
gi|4507241 SSRP1 Structure specific recognition protein 1 2.12 8 2.640 1 0.01 2 −21.042
gi|4506103 E2AK2 Eukaryotic translation initiation factor
2-alpha kinase 2 isoform a
1.95 6 2.760 10 3.010 1.59 6 1.972
gi|4506003 PP1A Protein phosphatase 1, catalytic
subunit, alpha isoform 1
0.94 23 −0.352 1.91 3 4.587 3 0.699
gi|112789562 IF16 Interferon, gamma-inducible protein 16 1.70 7 2.314 3 2.858 1.90 7 2.219 4 3.824
gi|42516576 GLRX5 Glutaredoxin 5 1.84 3 1.658 4 3.180
gi|166706903 GBP1 Guanylate binding protein 1,
interferon-inducible, 67 kDa
1.81 10 2.380 9 2.933
gi|38016914 SAMH1 SAM domain- and HD domain
containing protein 1
1.71 2 4.006 4 1.599
gi|50592994 THIO Thioredoxin 0.98 8 −0.430 11 0.070 1.69 2 −0.620 6 2.876
gi|48762920 K6PL Liver phosphofructokinase 1.69 5 0.603 3 3.920
gi|52630342 1C07 Major histocompatibility complex,
class I, C precursor
1.67 14 0.382 16 3.194 1.27 3 1.007
gi|22035653 APOL2 Apolipoprotein L2 1.64 3 2.583 2 1.951
gi|5031777 IDH3A Isocitrate dehydrogenase 3 NAD(+)
alpha precursor
0.97 18 −0.385 15 0.062 1.57 2 2.162 2 1.892
gi|223718097 OXA1L Oxidase (cytochrome c) assembly
1-like
1.57 1 2 2.576
gi|19923973 KCD12 Potassium channel tetramerization
domain containing 12
1.07 7 0.328 1.57 2 1.969 3 1.999
gi|4758786 NDUS2 NADH dehydrogenase (ubiquinone)
Fe-S protein 2
1.55 3 2.985 2 0.692 1.56 3 1.880
gi|5031863 LG3BP Galectin 3 binding protein 1.55 7 1.474 13 2.083
gi|62530384 ECI1 dodecenoyl-Coenzyme A delta
isomerase precursor
0.99 12 −0.313 2 0.730 1.55 4 2.281 3 1.564
gi|9506689 EXOS4 Exosome component 4 1.08 5 0.297 1.53 2 4.810 5 0.132
(Continued)
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Table 2 | Continued
Accession HGNC ID Name Cytoplasm Nucleus
Standard Proteominer Standard Proteominer
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Proteins detected multiple times/regulated at least once
gi|33356547 MCM2 Minichromosome maintenance
complex component 2
1.13 28 0.439 28 0.584 8.04 3 9.026
gi|5453740 ML12A Myosin, light chain 12A, regulatory,
non-sarcomeric
6.89 13 10.050 0.84 10 −0.811
gi|24307901 IFI35 Interferon-induced protein 35 3.71 2 6.811 3.04 3 5.269
gi|5174513 SMAD3 mothers against decapentaplegic
homolog 3 isoform 1
1.23 1 2.03 3 3.044
gi|4503049 CRIP2 Cysteine-rich protein 2 1.99 4 2.809 1.18 3 0.677
gi|148747351 PACN2 Protein kinase C and casein kinase
substrate in neurons 2
1.70 3 2.742 1.04 2 0.103
gi|21956645 MTPN Myotrophin 1.07 3 0.323 1.68 2 2.211
gi|33469966 SCFD1 Vesicle transport-related protein
isoform a
0.98 3 1.814 8 −0.875 1.68 4 2.439
gi|5902076 SRSF1 Splicing factor, arginine/serine-rich 1
isoform 1
1.63 2 1.994 1.07 14 0.109 25 0.336
gi|39780588 TSR1 TSR1, 20S rRNA accumulation 1.00 1 1.58 4 2.147
gi|13540606 CLPB Caseinolytic peptidase B 1.52 2 2.158 0.49 1
Proteins detected once
gi|17921993 TBA3C Tubulin, alpha 3c 100 86 24.036
gi|31543983 ARFG2 ADP-ribosylation factor GTPase
activating protein 2
5.73 3 8.278
gi|4758442 GMFB Glia maturation factor, beta 3.03 2 5.754
gi|19923597 SP130 Sin3A-associated protein, 130 kDa
isoform b
2.49 2 4.318
gi|13375616 FADS3 Fatty acid desaturase 3 2.14 2 3.931
gi|74271837 GLNA Glutamine synthetase 2.01 3 2.852
gi|4502209 ARF5 ADP-ribosylation factor 5 1.90 3 2.747
gi|70608211 NT5C3 5(-Nucleotidase, cytosolic III isoform 2 1.88 3 2.587
gi|20631967 BAX Apoptosis regulator BAX isoform sigma 1.87 2 2.559
gi|4757876 BST2 Bone marrow stromal cell antigen 2 1.87 4 2.666
gi|222144328 MYL12B3 Myosin regulatory light chain MRCL2
isoform B
1.83 6 2.847
gi|53828918 PGTA Rabgeranylgeranyltransferase alpha 1.83 2 2.459
gi|190014625 RRP44 DIS3 mitotic control isoform b 1.81 2 2.810
gi|5729820 SYFM Phenylalanyl-tRNAsynthetase 2
precursor
1.79 2 2.382
gi|4505467 NT5E 5′ Nucleotidase isoform 1
preproprotein
1.74 2 2.618
gi|4505895 PLRG1 Pleiotropic regulator 1 (PRL1 homolog,
Arabidopsis)
1.71 2 2.540
gi|4505587 PA1B3 Platelet-activating factor
acetylhydrolase, isoform Ib, gamma
subunit
1.67 2 2.634
gi|28395033 RHOC Ras homolog gene family, member C
precursor
1.62 18 1.981
gi|148536825 CO4A1 Alpha 1 type IV collagen preproprotein 1.59 2 2.380
(Continued)
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Table 2 | Continued
Accession HGNC ID Name Cytoplasm Nucleus
Standard Proteominer Standard Proteominer
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
gi|71044479 DIDO1 Death inducer-obliterator 1 isoform c 1.58 3 2.153
gi|9955963 ABCB6 ATP-binding cassette, sub-family B,
member 6
1.56 4 2.294
gi|56676335 RIF1 RAP1 interacting factor 1 1.56 2 2.083
gi|40254978 FIP1 FIP1 like 1 isoform 1 1.54 4 2.041
gi|7706481 CAB39 Calcium binding protein 39 1.54 5 2.203
gi|221316634 LMO7 LIM domain only 7 isoform 2 1.53 6 1.991
gi|194473714 LXN Latexin 1.52 3 2.155
gi|8923219 TRM1 tRNAmethyltransferase 1 isoform 1 1.50 6 2.072
DOWN-REGULATED PROTEINS
Proteins detected in multiple similar fractions
gi|4507241 SSRP1 FACT complex subunit SSRP1 2.12 8 2.640 1 0.012 2 −21.042
gi|4506457 RCN2 Reticulocalbin 2 precursor 0.86 14 −0.076 27 −0.993 0.32 2 −4.994
gi|4505751 PROF2 Profilin 2 isoform b 0.91 8 −0.215 9 −0.601 0.46 3 −3.447
gi|7661832 SSU72 Ssu72 RNA polymerase II CTD
phosphatase homolog
0.84 3 −1.873 3 −0.127 0.52 3 −2.902
gi|4506929 SH3G1 SH3 domain GRB2-like 1 0.57 5 −3.424 3 −1.835 27.85 3 21.873 8 −1.062
gi|72534660 SRSF7 Splicing factor, arginine/serine-rich 7 0.57 2 0.155 5 −3.972 0.91 6 −1.680 12 0.031
gi|7661672 PDIP2 DNA polymerase delta interacting
protein 2
0.88 5 −0.696 3 −0.516 0.58 2 −2.426
gi|4758340 SYFA Phenylalanyl-tRNAsynthetase, alpha
subunit
0.96 9 −0.532 13 −0.003 0.58 4 −2.095 6 −2.721
gi|31543415 G45IP Growth arrest and
DNA-damage-inducible, gamma
interacting protein 1
0.60 3 −21.042 4 0.149
gi|45359846 G3BP2 Ras-GTPase activating protein SH3
domain-binding protein 2 isoform b
0.60 12 −3.099 9 −1.520
gi|4507467 BGH3 Transforming growth factor,
beta-induced, 68kDa precursor
0.64 7 −3.152 6 −1.196 0.82 5 −0.890
gi|40353740 LARP4 La-related protein 4 isoform b 0.65 1 3 −2.585 1.27 2 0.997
gi|4503523 EIF3D Eukaryotic translation initiation factor 3
subunit D
1.07 8 0.672 3 −0.582 0.66 4 −2.237 1
Proteins detected multiple times/regulated at least once
gi|16554629 WDR5 WD repeat domain 5 0.011 4 −23.627 1.00 2 0.001 2 −0.034
gi|4502337 ZA2G Alpha-2-glycoprotein 1, zinc 0.11 2 −8.924 0.012 2 −19.301
gi|60097902 FLG Filaggrin 0.01 2 −18.099 1.99 1
gi|4557894 LYSC Lysozyme precursor 0.11 5 −8.960 0.17 1
gi|4505821 PIP Prolactin-induced protein 0.33 3 −4.601 0.29 2 −5.451
gi|58530840 DESP Desmoplakin isoform I 0.30 11 −4.902 0.47 2 −3.371
gi|8922652 ARFG1 ADP-ribosylation factor GTPase
activating protein 1 isoform a
1.07 4 0.290 0.46 2 −3.437
gi|116235460 YTHD3 YTH domain family, member 3 0.50 4 −2.822 0.88 5 −3.099 11 0.145
gi|13129040 SPATA5L1 Spermatogenesis associated 5-like 1 1.12 2 0.454 0.52 2 −3.090
gi|145580575 CTBP2 C-Terminal binding protein 2 isoform 2 1.07 9 0.282 0.53 4 −2.827
gi|4826730 MTOR FK506 binding protein 12-rapamycin
associated protein 1
0.99 2 −0.092 0.55 4 −2.860
gi|47271443 SRSF2 Splicing factor, arginine/serine-rich 2 0.56 4 −3.068 1.35 5 −1.187 3 3.590
(Continued)
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Table 2 | Continued
Accession HGNC ID Name Cytoplasm Nucleus
Standard Proteominer Standard Proteominer
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
gi|4506901 SRSF3 Splicing factor, arginine/serine-rich 3 0.60 5 −2.120 0.99 12 0.465 17 −0.448
gi|4885245 FOSL2 FOS-like antigen 2 0.91 2 −0.402 0.60 2 −2.271
gi|20127486 PLIN3 Perilipin-3 isoform 1 1.00 24 −0.045 0.61 3 −2.391
gi|7657176 CNPY2 Canopy 2 homolog 0.96 12 −0.242 0.61 2 −2.337
gi|56118310 NUCKS Nuclear casein kinase and
cyclin-dependent kinase substrate 1
1.01 4 0.017 0.66 6 −2.022
gi|89276751 CO5A1 Alpha 1 type V collagen preproprotein 0.86 10 −0.815 0.66 3 −2.022
Proteins detected once
gi|4885477 MYG Myoglobin 0.012 2 −18.099
gi|61835172 FXR1 Fragile X mental retardation-related
protein 1 isoform c
0.012 2 −19.301
gi|119703744 DSG1 Desmoglein 1 preproprotein 0.10 4 −9.424
gi|62122917 FILA2 Filaggrin family member 2 0.11 3 −9.185
gi|54607120 TRFL Lactotransferrin precursor 0.12 5 −8.747
gi|189458821 TGM3 Transglutaminase 3 precursor 0.18 2 −6.951
gi|38348366 SBSN Suprabasin 0.21 2 −6.925
gi|4885165 CYTA Cystatin A 0.22 2 −6.580
gi|15187164 LACRT Lacritin precursor 0.24 2 −5.876
gi|170296790 A8CED1 Mesotrypsin isoform 1 preproprotein 0.25 6 −6.665
gi|239755818 LOC1002933513 PREDICTED: hypothetical protein
isoform 2
0.35 2 −4.275
gi|221316620 CD123 Cell division cycle 12 0.38 3 −5.063
gi|116686122 KIF4A Kinesin family member 4 0.42 2 −4.187
gi|4501889 ACTH Actin, gamma 2 propeptide 0.44 85 −4.302
gi|14327896 CCNB1 cyclin B1 0.48 2 −3.487
gi|48762942 HIP1R Huntingtin interacting protein-1-related 0.50 2 −3.304
gi|155722990 SLC4A1AP Kanadaptin 0.53 2 −3.018
gi|50658084 BCAT2 Branched chain aminotransferase 2,
mitochondrial
0.55 4 −3.200
gi|47825361 NCRP1 Non-specific cytotoxic cell receptor
protein 1 homolog
0.56 2 −2.346
gi|4502951 CO3A1 Collagen type III alpha 1 preproprotein 0.57 5 −2.948
gi|114796644 RCC1 Regulator of chromosome
condensation 1 isoform a
0.58 3 −2.920
gi|7705999 TMEM9 Transmembrane protein 9 0.58 2 −2.911
gi|19882251 CYTN Cystatin SN precursor 0.58 3 −2.238
gi|154240704 TM192 Transmembrane protein 192 0.58 2 −2.210
gi|82546824 FOXK1 Forkhead box K1 0.58 3 −2.866
gi|190684694 UBP8 Ubiquitin specific peptidase 8 0.59 2 −2.567
gi|221219053 DNAJC7 DnaJ (Hsp40) homolog, sub-family C,
member 7 isoform 1
0.59 3 −2.795
gi|7657655 TRAM1 Translocation associated membrane
protein 1
0.63 3 −2.199
gi|4557555 EGLN Endoglin isoform 2 precursor 0.64 2 −2.420
gi|46909600 ADA15 A disintegrin and metalloproteinase
domain 15 isoform 6 preproprotein
0.64 3 −2.370
gi|8393009 FFR Chromosome 11 open reading frame2 0.64 2 −2.346
(Continued)
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Table 2 | Continued
Accession HGNC ID Name Cytoplasm Nucleus
Standard Proteominer Standard Proteominer
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
Inf/
Mock1
#
Peps
z-
Score
#
Peps
z-
Score
gi|109255232 CE170 Centrosomal protein 170 kDa isoform
gamma
0.65 2 −2.330
gi|63176611 SLTM SAFB-like transcription modulator
isoform a
0.65 5 −2.051
gi|5453958 PPP5 Protein phosphatase 5, catalytic
subunit
0.66 3 −2.249
gi|8922331 MGN2 Mago-nashi homolog B 0.66 4 −1.986
gi|30061491 E41L1 Erythrocyte membrane protein band
4.1-like 1 isoform b
0.665 5 −2.178
1Weighted H:L ratios, scaled to number of measured peptides in each sample, if detected in both Standard and Proteominer samples.
2Bolding indicates a significant z-score (95% confidence), either >1.960 or <–1.960.
3Gene removed from NCBI database.
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FIGURE 4 |Western blot validation of experimentally determined SILAC
ratos. HeLa cells were harvested and lysed with 0.5% NP-40 detergent,
nuclei removed, and cytosolic fractions dissolved in SDS electrophoresis
sample buffer. Proteins were resolved in 10% mini-SDS-PAGE, transferred
to PVDF, and probed with indicated antibodies. Bands were visualized, and
intensities measured, with an Alpha Innotech FluorChem®Q Multi Image®
III instrument. Molecular weight standards are indicated at left and
SILAC-measured ratios are indicated on the right. ∗, No viral proteins
measured by SILAC as these are absent from mock-infected samples.
interact with few partners, but several, including WDR5, appear
as interaction “hubs.” We identified numerous other interaction
hubs, such as LGAL53 and NF-KB which were not, themselves, sig-
nificantly altered, but which interacted with several differentially
regulated proteins.
PROTEINS DOWN-REGULATED BY REOVIRUS INFECTION ARE
ASSOCIATED WITH CELL DIFFERENTIATION, DERMAL
DIFFERENTIATION, AND MOLECULAR BINDING
Down-regulated proteins were assigned to 33 biological processes
at 95% confidence (Figure 5, lower), that included cell differentia-
tion, peptide cross-linking, and ectoderm and endoderm devel-
opment. Down-regulated proteins were also assigned to seven
functional groups, including structural molecule activity and var-
ious factor binding roles (Figure 5). IPA-generated GO categories
indicated down-regulated proteins were enriched in unknown cat-
egories whereas there were proportionally fewer down-regulated
enzymatic and transporter categories (Figure 6A). Additional
IPA pathway analyses indicated numerous components of the
“Interferon signaling” and “Role of PKR in interferon induc-
tion and antiviral response” canonical pathways were significantly
up-regulated, whereas numerous arms of the “Regulation of actin-
based motility by rho” canonical pathway were down-regulated
(data not shown).
PROTEOMINER ENRICHMENT LED TO IDENTIFICATION OF
COMPARABLE NUMBERS OF PROTEINS, BUT PM-ENRICHED PROTEINS
WERE IDENTIFIED BY FEWER PEPTIDES
As indicated earlier, 1,903 proteins were identified in the stan-
dard cytosolic fraction, compiled from 24,927 H:L peptide pairs
(Table 1). This corresponds to an average of 13.1 peptides/protein
(SD± 20.5; Figure 7). In contrast, PM enrichment of the cytoso-
lic fraction led to identification of 17,484 H:L peptide pairs and
1,657 proteins (average= 10.3 peptides, ±15.8). Slightly more
proteins were identified in the PM-enriched nuclear fraction than
in the standard nuclear fraction, but the average numbers of
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FIGURE 5 | Gene ontology analyses of up-regulated and down-regulated
proteins. The proteins identified inTable 2 were imported into the DAVID
gene ontology suite of programs at the NIAID, gene identifications converted
by that program, and ontological functions determined by GOTERM.
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FIGURE 6 | Molecular pathways of regulated proteins. Proteins and their
levels of regulation were imported into the Ingenuity Pathways Analysis
(IPA®) tool and interacting pathways were constructed. (A) Ontological
classifications of all measured proteins (Total) as well as those significantly
up- and down-regulated. The indicated ontological classifications start at the
top of each pie chart and are presented clockwise. (B) Merged networks,
containing all molecules present in each of the five individual networks. (C)
The top five networks, identified at 95% confidence and each of which
contained 11 or more “focus” molecules (molecules significantly up- or
down-regulated), with pathway names indicated. Solid lines: direct known
interactions; dashed lines: suspected or indirect interactions; red:
significantly up-regulated proteins; pink: moderately up-regulated proteins;
gray: proteins identified but not significantly regulated; light green:
moderately down-regulated proteins; dark green: significantly
down-regulated proteins; white: proteins known to be in network, but not
identified in our study.
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Table 3 | Correlation and overlap between various sample preparation schemes.
Cyto St vs.
Cyto PM1
Nuc St vs.
Nuc PM
Cyto St vs.
Nuc St
Cyto PM vs.
Nuc PM
Biological
replicate2
Technical
replicate2
Percentage of overlap 73.7 67.9 65.4 68.0 67.3 81.5
Overall correlation (r2) 0.444 0.255 0.159 0.606 0.038–0.057 0.660
Correlation (r2) for up- and
down-regulated proteins only
0.236 0.119 0.046 0.448 0.156–0.174 0.414
1Cyto, cytosolic fraction; Nuc, nuclear fraction; St, standard 2D-LC/MS; PM, Proteominer.
2Biological and technical values observed in another study Coombs et al. (2010); and unpublished.
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FIGURE 7 | Box plots of number of peptides identified under each
experimental condition. The box encompasses the upper and lower
quartile. Median values for each condition are indicated by the full horizontal
line inside each box, the average is indicated by the shorter thick line, and
SDs are indicated by upward error bars , all identified proteins; , only
proteins identified as common to both the standard and PM analyses.
identified peptides, and the corresponding SD, were also lower in
the PM-enriched fraction (Figure 7). This pattern was seen irre-
spective of whether all proteins were examined (white boxes), or
only proteins common to both the standard and PM enrichment
fractions (gray boxes). Previous studies in our lab have shown
that biologic replicates have ∼67% overlap and an r2 degree of
correlation of about 0.04, whereas technical replicates of the same
biologic replicate have ∼82% overlap and an r2 value of about
0.66 (Coombs et al., 2010; Table 3). Comparisons of the overlap
and r2 values between standard preparations and their cognate
PM enrichment preparations showed intermediate values of∼68–
74% overlap and r2 ranging between 0.25 and 0.44 (Table 3),
suggesting the PM enrichment strategy did not add substantially
to information provided by standard preparations.
NOTE ADDED IN PROOF
The Mann laboratory has recently used label-free approaches to
determine the relative quantity of each of thousands of proteins
in a variety of human cell lines, including HeLa cells (Geiger et al.,
2012). As a more direct analysis to determine whether application
of Proteominer beads led to identification of lower abundance
proteins, we sorted our datasets and determined there were no
significant differences in the average and median quantities of pro-
teins identified by either of the two methods in each of the cytosolic
and nuclear fractions, further strengthening the main conclusion
of this study, that non-biased enrichment using this particular
affinity method does not contribute to deeper proteomic mining.
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